Hite Christopher has filed 12 insider transactions across 3 companies since May 2024.
Most recent transaction: a grant/award of 24263 shares of Royalty Pharma plc ($RPRX) on May 06, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | Royalty Pharma plc | $RPRX | Hite Christopher | EVP & Vice Chairman | A | Class A Ordinary Shares | 24263 | $0.00 | 779,399.0000 | 564,455,000 | 3.21% | 0.00% |
| April 16, 2026 | Kailera Therapeutics, Inc. | $KLRA | Hite Christopher | Not found | A | Stock Option (right to buy) | 38300 | $0.00 | 38,300.0000 | 0 | 9999.99% | 0.00% |
| March 5, 2026 | Vera Therapeutics, Inc. | $VERA | Hite Christopher | Not found | A | Stock Option (right to buy) | 24937 | $0.00 | 24,937.0000 | 63,928,066 | 9999.99% | 0.04% |
| Feb. 11, 2026 | Royalty Pharma plc | $RPRX | Hite Christopher | EVP & Vice Chairman | A | Class A Ordinary Shares | 26626 | $0.00 | 755,136.0000 | 564,455,000 | 3.65% | 0.00% |
| Nov. 5, 2025 | Royalty Pharma plc | $RPRX | Hite Christopher | EVP & Vice Chairman | A | Class A Ordinary Shares | 6168 | $0.00 | 728,510.0000 | 566,754,000 | 0.85% | 0.00% |
| Aug. 6, 2025 | Royalty Pharma plc | $RPRX | Hite Christopher | EVP & Vice Chairman | A | Class A Ordinary Shares | 3696 | $0.00 | 722,342.0000 | 594,108,000 | 0.51% | 0.00% |
| May 16, 2025 | Royalty Pharma plc | $RPRX | Hite Christopher | EVP & Vice Chairman | A | Class E Ordinary Shares | 1238789 | $0.00 | 1,238,789.0000 | 594,108,000 | 9999.99% | 0.21% |
| May 8, 2025 | Royalty Pharma plc | $RPRX | Hite Christopher | EVP & Vice Chairman | A | Class A Ordinary Shares | 48646 | $0.00 | 718,646.0000 | 594,108,000 | 7.26% | 0.01% |
| Feb. 14, 2025 | Royalty Pharma plc | $RPRX | Hite Christopher | EVP & Vice Chairman | C | LP interests in RPI US Partners 2019, LP | 30000 | $0.00 | 86,641.0000 | 594,108,000 | 25.72% | 0.01% |
| Feb. 14, 2025 | Royalty Pharma plc | $RPRX | Hite Christopher | EVP & Vice Chairman | C | Class A Ordinary Shares | 300000 | $0.00 | 670,000.0000 | 594,108,000 | 81.08% | 0.05% |
| May 13, 2024 | Royalty Pharma plc | $RPRX | Hite Christopher | EVP & Vice Chairman | C | LP interests in RPI US Partners 2019, LP | 30000 | $0.00 | 541.0000 | 602,900,000 | 98.23% | 0.00% |
| May 13, 2024 | Royalty Pharma plc | $RPRX | Hite Christopher | EVP & Vice Chairman | C | Class A Ordinary Shares | 300000 | $0.00 | 370,000.0000 | 602,900,000 | 428.57% | 0.05% |